Gabelli Funds LLC Exact Sciences Corp Transaction History

Gabelli Funds LLC

  • $12.8 Billion
  • Q3 2024

A detailed history of Gabelli Funds LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Gabelli Funds LLC holds 12,790 shares of EXAS stock, worth $716,879. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,790
Previous 12,790 -0.0%
Holding current value
$716,879
Previous $540,000 61.11%
% of portfolio
0.01%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023
SELL
$62.68 - $95.05 $62,680 - $95,050
-1,000 Reduced 7.25%
12,790 $1.2 Million
Q1 2023

May 12, 2023
SELL
$47.19 - $70.77 $40,111 - $60,154
-850 Reduced 5.81%
13,790 $935,000
Q4 2022

Feb 13, 2023
SELL
$30.35 - $53.15 $30,350 - $53,150
-1,000 Reduced 6.39%
14,640 $724,000
Q3 2022

Nov 10, 2022
BUY
$31.97 - $49.37 $107,163 - $165,488
3,352 Added 27.28%
15,640 $508,000
Q2 2022

Aug 12, 2022
BUY
$35.61 - $76.23 $103,340 - $221,219
2,902 Added 30.92%
12,288 $484,000
Q1 2022

May 13, 2022
BUY
$57.56 - $82.54 $93,880 - $134,622
1,631 Added 21.03%
9,386 $656,000
Q4 2021

Feb 11, 2022
BUY
$72.5 - $100.68 $159,282 - $221,193
2,197 Added 39.53%
7,755 $604,000
Q3 2021

Nov 12, 2021
BUY
$90.24 - $124.05 $20,394 - $28,035
226 Added 4.24%
5,558 $531,000
Q2 2021

Aug 13, 2021
SELL
$93.66 - $139.27 $1,123 - $1,671
-12 Reduced 0.22%
5,332 $663,000
Q1 2021

May 14, 2021
BUY
$116.57 - $155.01 $214,955 - $285,838
1,844 Added 52.69%
5,344 $704,000
Q4 2020

Feb 05, 2021
SELL
$99.61 - $142.12 $49,805 - $71,060
-500 Reduced 12.5%
3,500 $464,000
Q3 2020

Nov 06, 2020
BUY
$72.92 - $102.01 $36,460 - $51,005
500 Added 14.29%
4,000 $408,000
Q1 2020

May 14, 2020
BUY
$37.9 - $104.44 $37,900 - $104,440
1,000 Added 40.0%
3,500 $203,000
Q4 2019

Feb 14, 2020
BUY
$77.66 - $99.74 $194,150 - $249,350
2,500 New
2,500 $231,000

Others Institutions Holding EXAS

# of Institutions
661
Shares Held
162M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.92B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Gabelli Funds LLC Portfolio

Follow Gabelli Funds LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email